Matinas BioPharma Hldgs Stock (AMEX: MTNB) stock price, news, charts, stock research, profile.
Open | $0.180 |
Close | $0.182 |
Volume / Avg. | 766.876K / 1.540M |
Day Range | 0.177 - 0.190 |
52 Wk Range | 0.110 - 0.890 |
Market Cap | $45.147M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 37 |
Short Interest | 1.34% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Matinas BioPharma Hldgs (AMEX: MTNB) through any online brokerage.
Other companies in Matinas BioPharma Hldgs’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Immuneering (NASDAQ:IMRX) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for Matinas BioPharma Hldgs (AMEX: MTNB) was reported by BTIG on Wednesday, October 11, 2023. The analyst firm set a price target for 3.00 expecting MTNB to rise to within 12 months (a possible 1539.34% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $0.183 last updated Today at April 23, 2024 at 4:41 PM EDT.
There are no upcoming dividends for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.